Envoy Medical (COCH) EBT Margin (2022 - 2026)
Envoy Medical (COCH) reported EBT Margin of 15956.41% for Q1 2026, down 377815.0% on a YoY basis from N/an in Q1 2025, and down 87.43% sequentially from 8513.33% in Q4 2025.
Envoy Medical (COCH) EBT Margin (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of EBT Margin data on file, last reported at 15956.41% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 377815.0% year-over-year to 15956.41%; the trailing twelve-month figure through Mar 2026 stood at 10461.97% (up 91336917.0% YoY), and the FY2025 full-year result was 9900.41%, up 86047.0% from the prior year.
- EBT Margin declined to 15956.41% in Q1 2026, from 8513.33% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 10919.84% in Q3 2022 to a low of 3313632.14% in Q3 2024.
- A 5-year average of 234730.02% and a median of 8447.46% in 2024 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 330852589 bps in 2024 and jumped 329892024 bps in 2025, its largest moves.
- Tracing COCH's EBT Margin over 5 years: stood at 5746.48% in 2022, then soared by 220 bps to 6895.79% in 2023, then plunged by 270 bps to 11745.24% in 2024, then gained by 28 bps to 8513.33% in 2025, then plunged by 87 bps to 15956.41% in 2026.
- Business Quant data shows COCH's EBT Margin at 15956.41% in Q1 2026, 8513.33% in Q4 2025, and 14711.9% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | -15,956.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,956.41% |
| Dec 31, 2025 | -8,513.33% |
| Sep 30, 2025 | -14,711.90% |
| Jun 30, 2025 | -7,300.00% |
| Mar 31, 2025 | -12,178.26% |
| Dec 31, 2024 | -11,745.24% |
| Sep 30, 2024 | -3,313,632.14% |
| Jun 30, 2024 | -135,813.24% |
| Mar 31, 2024 | -8,447.46% |
| Dec 31, 2023 | 6,895.79% |
| Sep 30, 2023 | -5,106.25% |
| Jun 30, 2023 | -1,614.29% |
| Mar 31, 2023 | 1,999.01% |
| Dec 31, 2022 | -5,746.49% |
| Sep 30, 2022 | 10,919.84% |